PROPANC BIOPHARMA, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2015 | — | $-3.1M | — |
| FY2016 | $1.2M | $-2.6M | — |
| FY2017 | $3.5M | $-5.4M | — |
| FY2018 | $4.7M | $-6.8M | — |
| FY2019 | $1.7M | $-4.3M | — |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2015 | — | $-3.1M | — |
| FY2016 | $1.2M | $-2.6M | — |
| FY2017 | $3.5M | $-5.4M | — |
| FY2018 | $4.7M | $-6.8M | — |
| FY2019 | $1.7M | $-4.3M | — |